Skip to content
← All news

Health

Global Surge in Antimicrobial‑Resistance Plans Stumbles Over Funding and Testing Gaps

WHO data reveal that 173 countries now have antimicrobial‑resistance action plans, but only 22 % have the funding and full implementation needed, while testing capacity and surveillance remain far below global targets, leaving billions at risk.

Wholehuman Collective News Desk2 min read
Editorial illustration: Global Surge in Antimicrobial‑Resistance Plans Stumbles Over Funding and Testing Gaps
AI-generated editorial illustration.

Policy Gains Mask Implementation Gaps

The latest WHO assessment shows that 173 countries now report having a national action plan to combat antimicrobial resistance, more than double the 79 that had such plans in 2017. Yet only about a fifth of those nations—roughly 22 %—have secured the funding and fully implemented the strategies outlined in their plans. The shortfall leaves billions of people exposed to drug‑resistant infections, a risk that escalated in 2023 when one in six laboratory‑confirmed bacterial infections were resistant to at least one antibiotic. WHO Director‑General Tedros Adhanom Ghebreyesus called the surge in plans encouraging but warned that an unfulfilled plan helps no one.

Testing Capacity Falls Short of Global Target

A critical bottleneck lies in diagnostic capacity. Only 36 % of countries report having a national reference laboratory equipped to test the priority bacteria and fungi, far below the global target of 80 % of nations possessing comprehensive resistance‑testing capability by 2030. Without reliable testing, clinicians may prescribe antibiotics that are ineffective or unnecessary, fueling further resistance and allowing outbreaks to go undetected. Strengthening laboratory networks is therefore essential not only for guiding individual patient treatment but also for informing public‑health responses and preserving the efficacy of existing antimicrobials. Investments in equipment, training and quality assurance are cited as priorities to close this gap.

Surveillance and Stewardship Remain Inconsistent

Guidelines and surveillance systems show similar unevenness. While 63 % of nations have issued recommendations on the appropriate use of antimicrobials, just over half have established mechanisms to monitor national antibiotic consumption and track resistance trends. These tools are vital for stewardship programmes that aim to reduce unnecessary prescribing and to detect emerging threats early. WHO urges countries to invest in infection‑prevention measures, ensure equitable access to essential medicines, and expand quality diagnostic services. The call aligns with World AMR Awareness Week’s theme, “One Health, one action: Prevent AMR now,” emphasizing coordinated action across human, animal and environmental sectors.